Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
15.67
+0.14 (0.90%)
At close: Jul 16, 2025, 4:00 PM
15.50
-0.17 (-1.08%)
After-hours: Jul 16, 2025, 5:28 PM EDT

Telix Pharmaceuticals Revenue

In the year 2024, Telix Pharmaceuticals had annual revenue of 783.21M AUD with 55.85% growth. Telix Pharmaceuticals had revenue of 209.62M in the quarter ending December 31, 2024, with 48.82% growth.

Revenue (ttm)
783.21M AUD
Revenue Growth
+55.85%
P/S Ratio
10.98
Revenue / Employee
1,887,246 AUD
Employees
415
Market Cap
5.32B undefined

Revenue Chart

Created with Highcharts 11.4.8Telix Pharmaceuticals Revenue - Annual5.21M5.21M7.60M7.60M160.1M160.1M502.5M502.5M783.2M783.2M20202021202220232024-200M400M600M800M

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024783.21M280.66M55.85%
Dec 31, 2023502.55M342.45M213.90%
Dec 31, 2022160.10M152.50M2,007.64%
Dec 31, 20217.60M2.38M45.71%
Dec 31, 20205.21M1.73M49.58%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson89.33B
Merck & Co.63.92B
AbbVie57.37B
AstraZeneca54.98B
Novartis AG53.22B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings